🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.80
-0.09 (-0.60%)
Nov 20, 2026, 11:47 AM EST - Market open

Aurinia Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Aurinia Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $18.5. The average 1-year stock price forecast is 25.00% higher than the current stock price, while the lowest is $16 (+8.11%) and the highest is $21 (+41.89%).

Price Target: $18.5 (+25.00%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$16$18.5$18$21
Change+8.11%+25.00%+21.62%+41.89%

Analyst Ratings

The average analyst rating for Aurinia Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jul '26Aug '26Oct '26Nov '26
Strong Buy444554
Buy000000
Hold333222
Sell000000
Strong Sell000000
Total777776

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bloom Burton
Bloom Burton
Buy
Maintains
$21
BuyMaintains$21+41.89%Nov 3, 2026
RBC Capital
RBC Capital
Hold
Reiterates
$16 → $18
HoldReiterates$16 → $18+21.62%Oct 30, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$17 → $18
BuyReiterates$17 → $18+21.62%Oct 21, 2026

Financial Forecast

Revenue This Year
330.19M
from 283.06M
Increased by 16.65%
Revenue Next Year
388.73M
from 330.19M
Increased by 17.73%
EPS This Year
0.97
from 2.07
Decreased by -53.14%
EPS Next Year
1.16
from 0.97
Increased by 19.59%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
45.61M134.03M175.51M235.13M283.06M330.19M
Revenue Growth
-9.01%193.89%30.95%33.97%20.38%16.65%
Gross Profit
-6.63M83.38M111.72M186.10M217.89M300.47M
Gross Margin
-14.53%62.21%63.66%79.15%76.98%91.00%
Operating Income
-180.74M-111.47M-85.79M12.52M116.26M155.42M
Net Income
-180.97M-108.18M-78.02M5.75M287.20M131.56M
EPS
----2.070.97
EPS Growth
----5,075.00%-53.14%
Forward PE
---24.0619.6915.26
Free Cash Flow
----135.41M120.00M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High331.3M
Avg330.2M
Low329.0M

Revenue Growth

Revenue Growth202620272028
High
17.0%
Avg
16.7%
Low
16.2%

EPS Forecast

EPS202620272028
High1.00
Avg0.97
Low0.93

EPS Growth

EPS Growth202620272028
High
-51.7%
Avg
-53.1%
Low
-55.1%